What Researchers Did
This retrospective cohort study investigated the necessity of routine hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss by comparing intravenous steroids, hyperbaric oxygen, or a combination of both in 300 patients.
What They Found
The combined treatment group (intravenous steroids + hyperbaric oxygen) showed the highest proportion of patients responding to therapy at 84% and complete recovery at 58%.
Therapy initiated within the first 2 weeks resulted in significantly higher hearing gains (p 240 mg/dl) was associated with significantly worse responses (p < 0.05).
What This Means for Canadian Patients
Canadian patients experiencing idiopathic sudden sensorineural hearing loss might achieve better outcomes with a combined approach of intravenous steroids and hyperbaric oxygen therapy.
For optimal results, this combined treatment should ideally be initiated within 14 days of hearing loss onset.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or with Canadian participants.
Study Limitations
As a retrospective cohort study, this research may be subject to selection bias and confounding factors inherent to its design.